Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

643 public trials 134 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment

NCT07281833

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +14 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • St. Elisabeth-Krankenhaus GmbH, Brustzentrum - Senologie Cologne, North Rhine-Westphalia, Germany
  • Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
  • Brustzentrum Niederrhein, Johanniter Bethesda Krankenhaus Mönchengladbach, North Rhine-Westphalia, Germany
View all 16 locations
View Trial Details
Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

NCT06369285

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Positive HER-2 Negative Breast Cancer, +6 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
View all 53 locations
View Trial Details

Related conditions